The comprehensive Mother & Baby Substance Exposure Toolkit was created by the California Perinatal Quality Care Collaborative, the California Maternal Quality Care Collaborative, and HMA Institute on Addiction. This toolkit provides information on treating mothers and newborns from the prenatal period through hospital discharge with a focus on opioid-related conditions.
The Veterans Administration’s Evidence Synthesis Program prepared this systematic review on the effectiveness of transcranial magnetic stimulation (TMS) to reduce symptoms in people with chronic pain, post-traumatic stress disorder, traumatic brain injury, and opiate addiction at the request from the Center for Compassionate Care Innovation.
This 2010 report describes the many programs White Bison, Inc., has developed to prevent addiction and create individual recovery and resiliency in American Indian and Alaska Native Communities including the Wellbriety model, the concept of the Healing Forest, and the Firestarter peer
This 2018 report from the Centers for Disease Control describes evidence-based strategies to prevent opioid overdose based on a review of the published evidence and consultation with subject matter experts. The report describes 10 strategies that could be implemented by public health officials, law enforcement, local organizations or other community leaders.
This article describes the case of an individual prescribed buprenorphine for opioid use disorder (OUD) who did not achieve treatment stability at the maximum dose allowed by the patient’s insurer of 24 mg daily.
An overview of the Moms and Babies program at the Decatur Correctional Center in Illinois which allows incarcerated women to keep their babies with them for the early development stages and provides the women with parenting education and support. The women are also provided with post-release community reentry services. Women participating in the program have significantly lower rates of recidivism. This report is part of the Addiction Policy Forum’s Spotlight series which highlights innovative programs to address the opioid crisis.
This one page document summarizes the conclusions of the 2019 National Academies report on medications for opioid use disorder.
This four page document presents the highlights from the 2019 National Academies report on medication assisted treatment for opioid use disorder. Funding Source: National Institute on Drug Abuse, National Institutes of Health; Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
This 2018 publication from the National Sheriff’s Association and the National Commission on Correctional Health Care provides guidance on how to create and manage a medication assisted treatment program
This 2019 review from Oregon’s Drug Use Research & Management Program examined whether removing Medicaid prior authorization requirements for medication assisted treatment for individuals with opioid use